Page 36 - manuscript_ijb05596
P. 36

hydroxypropyl methylcellulose. The hydrogel can locally and continuously release the

                   encapsulated  GT/siMMP-9  into  the  wound  tissue  through  heat-sensitive  controlled

                   release for 7 days, resulting in MMP-9 expression and obviously promoting diabetic
                   wound healing. Daidi Fan et al. 126  prepared TAsiRNA nanogels for the first time based

                   on  the  self-assembled  interaction  of  TA  and  siRNA.  This  highly  efficient  and

                   biodegradable nanogel was prepared into PHTB (TAsiRNA) hydrogel by crosslinking

                   with polyvinyl alcohol and human-like collagen. Electrical stimulation improved the in

                   vivo  release  of  PHTB  (TAsiRNA)  hydrogels  and  the  endocytosis  of  the  nanogels.

                   Combination therapy using electrical stimulation and TAsiRNA hydrogels accelerated

                   diabetic wound healing by lowering ROS and MMP9 levels, promoting macrophage

                   polarization,  collagen  production,  and  angiogenesis.  Li  Yan  et  al. 127   developed  a

                   supramolecular  peptide  hydrogel  doped  with  nanoparticles  for  local  delivery  of

                   siMMP-9.  siMMP-9  was  encapsulated  within  nanoparticles  fabricated  from

                   amphiphilic  cationic  lipid-like  compounds,  subsequently  embedded  within  a

                   supramolecular  peptide  hydrogel  formed  through  the  self-assembly  of  amphiphilic

                   peptides.  Not only  can the retention  time of sirNA-loaded NPs  in  wound tissue be
                   significantly prolonged, but also the gradual release of sirNA-loaded NPs from their

                   porous network can improve the siRNA uptake rate of keratinocytes, thereby achieving

                   efficient MMP9 silencing and significantly improving diabetic wound healing. Zecong

                   Xiao et al. 128  highlighted the critical role of m6A methylation in diabetic wound healing,

                   clarifying  the  mechanism  by  which  m6A  modification  regulates  MMP9  expression

                   during  this  process.  By  combining  enhanced  mRNA  m6A  modification  with  ROS

                   scavenging strategy, we utilized a FTO inhibitor loaded nanocolloidal hydrogel in a

                   diabetic model, which showed excellent wound healing effect.

                        Furthermore,  diabetic  wounds  represented  a  complex  chronic  pathological

                   condition resulting from the interplay of multiple systemic and local factors, where in

                   any single factor may exacerbate the wound during the healing process. Consequently,

                   the development of multifunctional hydrogels capable of simultaneously addressing

                   infection, inflammation, and impaired angiogenesis was crucial for clinical efficacy 129 .


                                                            35
   31   32   33   34   35   36   37   38   39   40   41